Feature Latest Stories
Laura Jones reports on a breakthrough therapy designation for rucaparib in ovarian cancer, data from the STRIVE trial comparing enzalutamide with bicalutamide, and a 5-year update of the pivotal phase III study comparing ipilimumab with dacarbazine.
Neil D. Shore, MD, reviews the COUGAR-302 trial data and the approval of abiraterone; and Ganesh S. Palapattu, MD, explains the benefits of a multidisciplinary clinic. View Now >>
John C. Byrd, MD, and others discuss treatment options in patients with follicular lymphoma. View Now >>
Most Popular Right Now